High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma

@article{Wolff2015HighthroughputSS,
  title={High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma},
  author={N. C. Wolff and Andrea Pav{\'i}a-Jim{\'e}nez and V. Tcheuyap and Shane Alexander and M. Vishwanath and Alana Christie and X. Xie and N. Williams and P. Kapur and Bruce A. Posner and R. McKay and J. Brugarolas},
  journal={Oncotarget},
  year={2015},
  volume={6},
  pages={16951 - 16962}
}
  • N. C. Wolff, Andrea Pavía-Jiménez, +9 authors J. Brugarolas
  • Published 2015
  • Medicine
  • Oncotarget
  • Renal cell carcinoma (RCC) accounts for 85% of primary renal neoplasms, and is rarely curable when metastatic. Approximately 70% of RCCs are clear-cell type (ccRCC), and in >80% the von Hippel-Lindau (VHL) gene is mutated or silenced. We developed a novel, high-content, screening strategy for the identification of small molecules that are synthetic lethal with genes mutated in cancer. In this strategy, the screen and counterscreen are conducted simultaneously by differentially labeling mutant… CONTINUE READING
    VHL and Hypoxia Signaling: Beyond HIF in Cancer
    • 20
    • Open Access
    TBK1 is a Synthetic Lethal Target in Cancer with VHL Loss.
    • 7
    • Open Access
    Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism
    • 2
    • Open Access
    Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs.
    • 17
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 45 REFERENCES
    A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy.
    • 224
    • Open Access
    Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
    • 420
    • Open Access
    Molecular genetics of clear-cell renal cell carcinoma.
    • 173
    • Open Access
    State of the Science: An Update on Renal Cell Carcinoma
    • 132
    • Open Access
    The VHL/HIF axis in clear cell renal carcinoma.
    • 219
    • Open Access
    Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
    • 496
    • Open Access
    Tumour suppression by the human von Hippel-Lindau gene product
    • 661